These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 758243)

  • 1. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
    Slattery JT; Levy G; Jain A; McMahon FG
    Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
    Jain A; McMahon FG; Slattery JT; Levy G
    Clin Pharmacol Ther; 1979 Jan; 25(1):61-6. PubMed ID: 758244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma protein binding on the anticoagulant action of warfarin in rats.
    Yacobi A; Levy G
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):405-8. PubMed ID: 1197921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
    Slattery JT; Yacobi A; Levy G
    J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of coumarin anticoagulants XXIX: Elimination kinetics and anticoagulant activity of (S)-(-)-warfarin in rats before and after chronic administration.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1275-7. PubMed ID: 903865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naproxen on protein binding of warfarin in human serum.
    Yacobi A; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):369-72. PubMed ID: 981793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of digoxin on plasma clearance and anticoagulant effect of warfarin in rats.
    Ogiso T; Iwaki M; Konishi Y
    J Pharmacobiodyn; 1984 Mar; 7(3):186-94. PubMed ID: 6747809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.
    Williams RL; Schary WL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Jul; 20(1):90-7. PubMed ID: 1277729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age as a determinant of sensitivity to warfarin.
    Shepherd AM; Hewick DS; Moreland TA; Stevenson IH
    Br J Clin Pharmacol; 1977 Jun; 4(3):315-20. PubMed ID: 901699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of coumarin anticoagulants. XLVI: Effect of treatment of phenobarbital on pharmacokinetics of (S)-(-)-warfarin in rats.
    Yacobi A; Slattery JT; Levy G
    J Pharm Sci; 1980 Jun; 69(6):634-6. PubMed ID: 7205571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-pharmacological and pharmacokinetic studies with naproxen].
    Boost G
    Arzneimittelforschung; 1975 Feb; 25(2A):281-7. PubMed ID: 1096900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin resistance with nafcillin therapy.
    Qureshi GD; Reinders TP; Somori GJ; Evans HJ
    Ann Intern Med; 1984 Apr; 100(4):527-9. PubMed ID: 6703546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.
    Wingard LB; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1978 Feb; 23(2):212-7. PubMed ID: 620483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of furosemide and bumetanide on warfarin metabolism and anticoagulant response.
    Nilsson CM; Horton ES; Robinson DS
    J Clin Pharmacol; 1978; 18(2-3):91-4. PubMed ID: 624779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.